Study of Cbl-b dynamics in peripheral blood lymphocytes isolated from patients with multiple sclerosis

Neuroscience Letters

Volumn 440, Issue 3, 2008, Pages 336-339

  Zhou, Wen bin ^a   Wang, Rui ^a   Deng, Yong ning ^a   Ji, Xiao bei ^a   Huang, Guo xiang ^a   Xu, Yuan zhong ^b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Cbl b; Multiple sclerosis; Patients; T lymphocytes; Ubiquitin ligase

Indexed keywords

CBL B ENZYME; MESSENGER RNA; UBIQUITIN PROTEIN LIGASE E3;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; TH1 CELL;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NONLINEAR DYNAMICS; PROTO-ONCOGENE PROTEINS C-CBL; RNA, MESSENGER;

EID: 45849103832     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.05.089     Document Type: Article

References (23)

1. Achmaier K.B., Krawczyk C., Kozieradzki I., Kong Y.Y., Sasaki T., and Oliveira-dos-Santos A. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403 (2000) 211-216
2. Adorini L. Immunotherapeutic approaches in multiple sclerosis. J. Neurol. Sci. 223 (2004) 13-24
3. Chiang Y.J., Kole H.K., Brown K., Naramura M., Fukuhara S., and Hu R.J. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403 (2000) 120-216
4. Correale J., Gilmore W., Mcmillan M., Li S., McCarthy K., and Le T. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T-cell clones during the course of multiple sclerosis. J. Immunol. 154 (1995) 2959-2968
5. Ettenberg S.A., Magnifico A., Cuello M., Nau M.M., Rubinstein Y.R., and Yarden Y. Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex. J. Biol. Chem. 276 (2001) 27677-27684
6. Evavold B.D., and Allen P.M. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252 (1991) 1308-1310
7. Evavold B.D., Sloan-Lancaster J., and Allen P.M. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14 (1993) 602-609
8. Fang D., Wang H.Y., Fang N., Altman Y., Elly C., and Liu Y.C. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J. Biol. Chem. 276 (2001) 4872-4878
9. Hallin E., Mellergard J., Vrethem M., Ernerudh J., and Ekerfelt C. In vitro Th2 deviation of myelin-specific peripheral blood lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 171 (2006) 156-162
10. Hanlon A., Jang S., and Salgame P. Cbl-b differentially regulates activation-induced apoptosis in T helper 1 and T helper 2 cells. Immunology 116 (2005) 507-512
11. Hicke L. A new ticket for entry into budding vesicles-ubiquitin. Cell 106 (2001) 527-530
12. Joazeiro C.A., Wing S.S., Huang H., Leverson J.D., Hunter T., and Liu Y.C. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286 (1999) 309-312
13. Krawczyk C., and Penninger J.M. Molecular controls of antigen receptor clustering and autoimmunity. Trends Cell. Biol. 11 (2001) 212-220
14. Li D., Gal I., Vermes C., Alegre M.L., Chong A.S., and Chen L. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J. Immunol. 173 (2004) 7135-7139
15. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., and Lublin F.D. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
16. Nicholson L.B., Greer J.M., Sobel R.A., Lees M.B., and Kuchroo V.K. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3 (1995) 397-405
17. Perrella O., Sbreglia C., Perrella M., Spetrini G., Gorga F., and Pezzella M. Interleukin-10 and tumor necrosis factor-alpha: model of immunomodulation in multiple sclerosis. Neurol. Res. 28 (2006) 193-195
18. Singh R.A., Zang Y.C., Shrivastava A., Hong J., Wang G.T., and Li S. Th1 and Th2 deviation of myelin-autoreactive T cells by altered peptide ligands is associated with reciprocal regulation of Lck, Fyn, and ZAP-70. J. Immunol. 163 (1999) 6393-6402
19. Tsitoura D.C., Verhoef A., Gelder C.M., O'Hehir R.E., and Lamb J.R. Altered T cell ligands derived from a major house dust mite allergen enhance IFN-gamma but not IL-4 production by human CD41 T cells. J. Immunol. 157 (1996) 2160-2165
20. Wang H.Y., Altman Y., Fang D., Elly C., Dai Y., and Shao Y. Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70. J. Biol. Chem. 276 (2001) 26004-26011
21. Windhagen A., Scholz C., Hollsberg P., Fukaura H., and Sette A. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2 (1995) 373-380
22. Zhang J., Bardos T., Li D., Gál I., Vermes C., and Xu J. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination. J. Immunol. 169 (2002) 2236-2240
23. Zheng N., Wang P., Jeffrey P.D., and Pavletich N.P. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102 (2000) 533-539